Senseonics Holdings, Inc.

NASDAQ:SENS

Medical - Devices

Healthcare
$9.74 -1.27%

-$0.09 today

Market cap
$533.56M
Beta
0.97
P/E (TTM)
-3.5
EPS (TTM)
-$1.90
52W Low $4.79High $12.58

Volume 0.87M

Average 0.71M

SENS Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Senseonics Holdings, Inc.NASDAQ: SENS

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables growth accelerates

Q1 FY2026 accounts payables of $870K (cash outflow) rose 2.1% year over year, ahead of the -2.7% change in trailing-twelve-month accounts payables. Sequentially, it fell 52.3% from the prior quarter.

Context

  • Accounts payables amounted to 3.5% of revenue in FY2025, down 4.7 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +2.1% holds above the trailing-twelve-month pace of -2.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$870K-52.3% QoQ
Last fiscal yearDec 2025
$1.22M+166.6% YoY
LTMMar 2026
$1.2M-2.7% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.1%——
1 year+166.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
1.22M USD
Year-over-year change
+166.6%

Accounts Payables vs competitors

How SENS compares with its peers on the latest reported figures

  • SENS's LTM Mar 2026 accounts payables of $1.2M is the 5th largest of the 6 companies compared; the peer median is $16.5M.
  • Its year-over-year change of -2.7% is the 2nd highest of 5, against a peer median of -23.6%.
  • Accounts payables amounts to 2.9% of revenue for SENS, versus a peer median of 1.0%.
SENS Competitors Peer median
Accounts Payables for SENS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DXCMDexCom, Inc.LTM Jun 2026$245.6M -36.9%+5.5%4.9%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$237M —+43.1%7.4%
PODDInsulet CorporationLTM Jun 2026$16.5M -10.3%—0.5%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$10.24M +155.8%-55.0%1.0%
SENSSenseonics Holdings, Inc.LTM Mar 2026$1.2M -2.7%—2.9%
BBNXBeta Bionics, Inc.LTM Mar 2026$1.14M -212.9%—1.0%
Peer median (excluding SENS) $16.5M-23.6%+5.5%1.0%

Competitors are the stored peer set for SENS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(302.47M)142.12M(60.39M)(78.62M)(69.11M)
Depreciation & Amortization1.24M985K1.28M1.48M91K
Deferred Income Tax229.17M0000
Stock-Based Compensation9.03M8.62M8.67M9.23M10.15M
Change in Working Capital(1.5M)(2.47M)(3.97M)865K(3.28M)
Accounts Receivables1.01M(478K)(2.19M)(2.7M)(6.77M)
Inventory(1.04M)(989K)(1.64M)696K(2.98M)
Accounts Payables(559K)(785K)2.3M(1.83M)1.22M
Other Working Capital(922K)(219K)(2.43M)4.7M5.24M
Other Non-Cash Items8.46M(215.56M)(15.76M)6.59M3.02M
Operating Cash Flow(56.08M)(66.31M)(70.16M)(60.47M)(59.13M)
Capital Expenditures(210K)(312K)(350K)(2.24M)(1.12M)
Acquisitions (Net)210K(27.19M)000
Purchases of Investments(154.51M)(104.71M)(68.54M)(58.02M)(100.69M)
Sales of Investments5.98M131.9M158.6M93.1M48.39M
Other Investing Activities(210K)27.19M000
Investing Cash Flow(148.75M)26.88M89.71M32.84M(53.42M)
Debt Repayment(2.84M)(2.93M)1.25M9.95M(20.4M)
Common Stock Issued200.37M34.17M7.38M18.36M100.73M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(227K)(1.49M)11.74M(1.48M)(2.15M)
Financing Cash Flow220.08M41.76M20.37M26.83M78.19M
Effect of Forex Changes00000
Net Change in Cash15.26M2.33M39.92M(797K)(34.36M)
Free Cash Flow(56.29M)(66.62M)(70.51M)(62.7M)(60.25M)

Senseonics Holdings, Inc.

NASDAQ:SENS

Intrinsic Alpha fair value

Locked

Current Price

$9.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.